Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Russo

Pediatric Gastroenterology Plano, TX Medical Doctor

NPI 1043272958 CMS profile 1537

7000 W Plano Pkwy Ste 110, Plano, TX 75093

Open in the dashboard

General payments

$19,171

126 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$6,762

3 holdings reported · through program year 2025

Through program year 2025, Michael Russo of Plano, TX is reported in the CMS Open Payments database as having received $19,171 across 126 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $6,762 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $387 14
2024 General $386 15
2023 General $338 13
2022 General $4,522 19
2021 General $13,000 34
2020 General $296 12
2019 General $243 19
2024 Ownership $3,278 1
2023 Ownership $3,278 1
2022 Ownership $206 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Russo
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Michael Russo were reported at $387. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Michael Russo Pediatric Gastroenterology median Middle half National median
2019 $243 $131 $41–$311 $163
2020 $296 $79 $23–$223 $114
2021 $13,000 $104 $32–$321 $132
2022 $4,522 $125 $37–$331 $149
2023 $338 $169 $55–$440 $160
2024 $386 $196 $73–$563 $164
2025 $387 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $16,678 9 payments
  2. AbbVie, Inc. $849 51 payments
  3. Regeneron Healthcare Solutions, Inc. $621 20 payments
  4. Genzyme Corporation $381 17 payments
  5. Alexion Pharmaceuticals, Inc. $124 6 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $100 4 payments
  7. W. L. Gore & Associates, Inc. $96 1 payment
  8. Nestle HealthCare Nutrition Inc. $47 2 payments
  9. Amgen Inc. $43 2 payments
  10. QOL Medical, LLC $34 3 payments
  11. Other $199 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $16,000 5 payments
  2. Food and Beverage $2,671 120 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System Surgery $12,000 4 payments
  2. Da Vinci Surgical System Surgery $4,678 5 payments
  3. HUMIRA $675 43 payments
  4. DUPIXENT Inflammation And Immunology $445 15 payments
  5. DUPIXENT Immunology $381 17 payments
  6. DUPIXENT Immunology And Inflammation $175 5 payments
  7. QULIPTA $99 5 payments
  8. EXCLUDER AAA Endoprosthesis $96 1 payment
  9. EOHILIA $57 2 payments
  10. AVSOLA $43 2 payments
  11. Other $407 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

126 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record